Retraction notice to “Corrigendum to ‘Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer’ [International Journal of Biological Macromolecules 248 (2023) 125782]” - Retraction Notice | RetractBase